Kevin D. Accola, MD

Kevin D. Accola , MD

Cardiovascular and Thoracic Surgeon

Heart, Lung and Vascular

Kevin Accola

Overview

Dr. Kevin D. Accola, MD is a board-certified internal medicine, hematology and oncology physician. Dr. Accola earned his medical degree from the University of Illinois at Chicago and completed his internship and medical residency at Baylor College of Medicine & Emory University School of Medicine. To date, he has performed approximately 9,000 cardiac surgical procedures, of which 2,400 (currently 300+ cases per year) involved heart valve operations. As an established member of the surgical community, Dr. Accola is a member of many medical organizations, including but not limited to, the Patient Advocacy Council, the Society of Thoracic Surgeons, the Florida Medical Association, the Florida Society of Thoracic Cardiovascular Surgeons Council,and the American College of Cardiology. Dr. Accola's cardiac specialties include mitral valve repair, aortic valve procedures, and ascending aortic aneurysm. His clinical interests comprise new valvular technology, cardiac protective drugs, and critical care studies.

Articles

Low-Dose vs Standard Warfarin After Mechanical Mitral Valve Replacement: A Randomized Trial

ANNALS OF THORACIC SURGERY

2023

Fractured sternal wire causing a cardiac laceration

JOURNAL OF CARDIOTHORACIC SURGERY

2023

Low-Dose Versus Standard Warfarin After Mechanical Mitral Valve Replacement: A Randomized Controlled Trial.

The Annals of thoracic surgery

2022

Commentary: Identifying patients who do not improve following surgical ventricular reduction: Is diastolic dysfunction the culprit?

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

2021

Commentary: Anticoagulation strategies: Awaiting a new paradigm.

The Journal of thoracic and cardiovascular surgery

2021

Commentary: Valve options for ischemic mitral regurgitation in an era of new technologies: ViV(a) la bioprosthetic.

The Journal of thoracic and cardiovascular surgery

2021

Reflections on 40 Years of Workforce Surveys: How the Times Have Changed

ANNALS OF THORACIC SURGERY

2020

Commentary: Business as usual: A thing of the past

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

2020

Reflections on a Career in Cardiothoracic Surgery: Maintaining Humanism in a Changing Environment

ANNALS OF THORACIC SURGERY

2020

Best Practices of Aortic Valve Replacement With the Edwards Intuity Elite Valve

ANNALS OF THORACIC SURGERY

2020

More Publication Information

Education & Training

Education

Rush Medical College

Residency

Baylor College Of Medicine; Emory University

Fellowship

Emory University Hospital

Specialty

Thoracic & Cardiovascular Surgery

Board Certifications

American Board of Thoracic Surgery

Associated Clinical Trials

NCT03706833

CLASP IID/IIF - A prospective, multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter mitral valve repair with the Edwards PASCAL Transcatheter Mitral Valve Repair System compared to Abbott Mitraclip in patients with degenerative mitral regurgitation.

Icon for trial | 2018-07 CLASP IID/IIF - A prospective, multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter mitral valve repair with the Edwards PASCAL Transcatheter Mitral Valve Repair System compared to Abbott Mitr

This study is currently enrolling.

The goal of this study is to assess the safety and performance of the PASCAL System in patients with symptomatic degenerative mitral regurgitation (DMR). Up to 300 participants will take part in this randomized study at up to 7 ...